Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II) (original) (raw)

Abstract

The effect of insulin-like growth factor II (IGF-II) on tumour development in the mouse mammary gland was studied. To promote extra IGF-II expression in the mammary gland, sheep beta-lactoglobulin regulatory elements were attached to the coding regions of the mouse Igf-2 gene and injected into the pronuclei of mouse zygotes. Mammary tumours developed in each of the four independent lines of mice which expressed transgene IGF-II in the gland. Tumours from two of the lines grew after transplantation to both male and female hosts. Primary tumours contained stromal and epithelial regions, but the tumours were dominated by mammary adenocarcinoma after transplantation. The tumours expressed high levels of Igf-2 mRNA transcribed from the integrated transgenes.

Access options

Subscribe to this journal

Receive 24 print issues and online access

$259.00 per year

only $10.79 per issue

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Zoology Department, Cancer Research Campaign Growth Factors, Oxford, UK
    P Bates

Authors

  1. P Bates
  2. R Fisher
  3. A Ward
  4. L Richardson
  5. DJ Hill
  6. CF Graham

Rights and permissions

About this article

Cite this article

Bates, P., Fisher, R., Ward, A. et al. Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II).Br J Cancer 72, 1189–1193 (1995). https://doi.org/10.1038/bjc.1995.484

Download citation

This article is cited by